Printer Friendly, PDF & Email


ISBT 128 Critically Needed as Biologics Unique Identifier

eHealth Exchange, the nation’s largest health information exchange network, wholeheartedly agrees the ISBT 128 international standard should be used in USCDI v2 as the globally-unique identifier for blood and other biologic products. The addition of Biologically Derived Products to USCDI v2 using the ISBT standard is critical to improving patient safety, coordination of care, and patient data portability for patients treated with biologic products of human origin. The addition of the Biologically Derived Products data class to USCDI v2 enables the exchange of granular details related to biologic products for the coordination of care between exchange participants, in addition to linkage of exposure records to adverse events that can be traced to specific biologic products of human origin

Log in or register to post comments